BERGER FRANKLIN M sold 5.0% of their position (25K shares) of ATEA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $81.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/17/2025ACC: 0000950170-25-006489
Director
Since Oct 2020
-25K
Net shares
Net seller
$81.5K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
25K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−15K
Price / share
$3.19
Trade value
$47.88K
% of position
3.1%
1/15/2025
481.90K→466.90K
Common Stock
Direct
Shares
−10K
Price / share
$3.36
Trade value
$33.61K
% of position
2.1%
1/16/2025
486.90K→476.90K
Total
Net shares
−25K
Net value
-$81.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/15/2025 | P · Purchase | −15K | $3.19 | $47.88K | 3.1% | 481.90K | 466.90K |
| Common Stock Direct | 1/16/2025 | P · Purchase | −10K | $3.36 | $33.61K | 2.1% | 486.90K | 476.90K |
| Total | −25K | -$81.50K | ||||||
Derivative Transactions0
No derivative transactions reported